search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Contract manufacturing On the rebound


While fears about certain devices, like ventilators, may have been miscalculated (at least in the West), there were more complex areas than PPE that were affected by the pandemic – but the impact wasn’t to supply, but demand. These were “Product areas like orthopaedics and dental, so more discretionary elective types of medical devices,” says Davies.


“Here we are in 2022, China and other places in Asia continue to produce [at scale] and imports haven’t changed dramatically.”


The reversal, he adds, has been significant. “They’ve done very well throughout 2021 and that’s continuing in 2022. It’s from a drop [in demand], but they’ve been having a good rebound since.” It’s the same story for surgical robotics, which Davies and his team of Fitch analysts believe is a medical device category that will see considerable growth over the next few years, as hospitals clear their elective procedure backlog. This ability to rebound was granted only by the pandemic situation improving somewhat so that elective procedures could continue, and that exemplifies just how powerless the medical device,


and by extension the contract manufacturing market is to external forces. Another indicative example is the price of raw materials, which have fluctuated during the pandemic, with metals and plastics still at a high cost. “There’s only so much any company can do,” says Davies. “It’s not like one raw material can be substituted for another.” The result has been an increase in costs across the board, with contract manufacturers having to increase their price to medical device companies, who are then having to increase their price to consumers.


One issue for component suppliers in the contract manufacturing market has been that, with the increased demand for their products spurred by elective surgeries resuming, there’s been a scramble for the materials they use. The result has been a longer wait for resources, which has meant quoting their medical device partners longer lead times. Some suppliers, like Wisconsin-based Custom Wire Technologies (CWT), tried to pre- empt this by stockpiling resources to keep lead times manageable. In a recent whitepaper on the topic, company president Bob Boldig described how he was “rolling the dice” and buying material in advance without necessarily having orders on the books to support it, just so that CWT had the ability to respond. The gamble paid off when the orders came rushing back alongside the demand for elective surgeries, but not all contract manufacturers took that risk, and long lead times still aren’t unusual. This is especially true for those reliant on the semiconductor market for their manufactured products, as the world is undergoing a historic shortage in the electronic component.


A less globalised world?


Your Experts in Laser Plastic Welding.


www.leister.com 32


If anything is to result in medical device companies reducing the amount of business they do with countries in Asia, it’s not going to be shortages – at least not while manufacturing costs remain low. Looking at the wider picture though, Davies says there were isolationist policies and a move away from globalisation seen within the medical device industry already – especially in the US due to its trade war with China. What remains to be seen, he adds, is what the global marketplace will look like now that Russia has effectively removed itself from it by waging war on Ukraine. “That is shifting a multi-decade trend for more globalisation,” he says. From here he believes several different scenarios could play out. “The world could return back to a more integrated global economy, or it could start splintering more, and that has implications for where countries source their medical devices and who they export to.” ●


Medical Device Developments / www.nsmedicaldevices.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128